Generic placeholder image

Current Women`s Health Reviews


ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Electronic Fetal Heart Rate Monitoring: The Future

Author(s): Taran Khangura and Edwin Chandraharan

Volume 9 , Issue 3 , 2013

Page: [169 - 174] Pages: 6

DOI: 10.2174/157340480903140131111807

Price: $65


Continuous electronic fetal heart rate monitoring (EFM) using a cardiotocograph (CTG) is associated with a high false positive rate of approximately 60%. Current scientific evidence does not support a significant reduction in perinatal mortality or cerebral palsy, except for a 50% reduction in neonatal convulsions. Recent scientific evidence has questioned the role of ‘peripheral’ tests of fetal wellbeing such as fetal scalp blood sampling (FBS), fetal scalp lactate and fetal pulse oximetry in reducing the false positive rate of CTG. Fetal ECG (ST-Analyzer or STAN) shows promise in reducing neonatal admissions and operative vaginal births. Computerized CTG analysis and Fetal Physiological Score (FPS) may help reduce errors associated with CTG interpretation.

Keywords: Fetal scalp blood sampling, fetal scalp lactate, ST-Analyzer (STAN), Fetal Physiological Score (FPS), computerised analysis.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy